Biomarkers in Diabetes Mellitus: From Discovery to Clinical Application
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 520
Special Issue Editors
Interests: lipids; lipoproteins; atherosclerosis; diabetes; biomarkers; laboratory diagnostics; medical biochemistry
Special Issues, Collections and Topics in MDPI journals
Interests: lipoprotein metabolism; cholesterol homeostasis; non-cholesterol sterols; sphingolipids; lipid biomarkers; dyslipidemia in pregnancy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Diabetes mellitus remains a significant global health challenge, characterized by rising prevalence and a substantial healthcare burden due to associated complications. Given the heterogeneous nature and multifactorial pathogenesis of diabetes, there is a critical need for accurate diagnostic and prognostic tools to improve patient outcomes. In this context, biomarkers play a pivotal role by enabling early detection, risk stratification, personalized therapeutic strategies and effective disease progression monitoring and treatment responses.
This Special Issue aims to highlight the latest advances in the discovery, validation and clinical translation of biomarkers associated with diabetes and its complications. We invite submissions of original research articles and review papers on genetic and biochemical biomarkers, particularly those that reflect the distinct molecular profiles of type 1, type 2 and gestational diabetes. We especially encourage contributions focused on predictive and prognostic biomarkers of microvascular and macrovascular diabetes complications. Submissions employing advanced molecular approaches, including lipidomics, transcriptomics, metabolomics and integrated multi-omics strategies, are highly welcome. We are also interested in translational and clinical research that explores the application of biomarkers in real-world healthcare settings, especially those that inform therapeutic decision making, as well as studies that support the integration of molecular biomarkers into precision medicine frameworks. We look forward to your valuable contributions.
Prof. Dr. Jelena Vekic
Prof. Dr. Aleksandra Zeljkovic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes mellitus
- biomarkers
- diabetes complications
- omics technologies
- risk stratification
- therapeutic response
- personalized medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
